ADHD drugs and serious cardiovascular events in children and young adults. Cooper WO, Habel LA, Sox CM, Chan KA, Arbogast PG, Cheetham TC, Murray KT, Quinn VP, Stein CM, Callahan ST, Fireman BH, Fish FA, Kirshner HS, O'Duffy A, Connell FA, Ray WA (2011) N Engl J Med 365: 1896-904 Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Conn PJ, Christopoulos A, Lindsley CW (2009) Nat Rev Drug Discov 8: 41-54 Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders. Conn PJ, Lindsley CW, Meiler J, Niswender CM (2014) Nat Rev Drug Discov 13: 692-708 Two critical periods of Sonic Hedgehog signaling required for the specification of motor neuron identity. Ericson J, Morton S, Kawakami A, Roelink H, Jessell TM (1996) Cell 87: 661-73 Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants. Ramamoorthy S, Blakely RD (1999) Science 285: 763-6 Teratogen-mediated inhibition of target tissue response to Shh signaling. Cooper MK, Porter JA, Young KE, Beachy PA (1998) Science 280: 1603-7 Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, Shriver LP, Ledent C, Cheng X, Carrier EJ, Mann MK, Giovannoni G, Pertwee RG, Yamamura T, Buckley NE, Hillard CJ, Lutz B, Baker D, Dittel BN (2007) Nat Med 13: 492-7 cAMP-dependent protein kinase regulates desensitization of the capsaicin receptor (VR1) by direct phosphorylation. Bhave G, Zhu W, Wang H, Brasier DJ, Oxford GS, Gereau RW (2002) Neuron 35: 721-31 Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U (2006) Neuron 51: 417-29 Mini-Oct and Oct-2c: two novel, functionally diverse murine Oct-2 gene products are differentially expressed in the CNS. Stoykova AS, Sterrer S, Erselius JR, Hatzopoulos AK, Gruss P (1992) Neuron 8: 541-58 Modulation of behavioral networks by selective interneuronal inactivation. Schmidt MJ, Horvath S, Ebert P, Norris JL, Seeley EH, Brown J, Gellert L, Everheart M, Garbett KA, Grice TW, Caprioli RM, Mirnics K (2014) Mol Psychiatry 19: 580-7 The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder. Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA (2004) Am J Psychiatry 161: 1990-7 Evidence against a physiologic role for acute changes in CNS insulin action in the rapid regulation of hepatic glucose production. Ramnanan CJ, Edgerton DS, Cherrington AD (2012) Cell Metab 15: 656-64 Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? Avison MJ, Nath A, Berger JR (2002) Trends Neurosci 25: 468-73 Dopamine transport currents are promoted from curiosity to physiology. Sulzer D, Galli A (2003) Trends Neurosci 26: 173-6 PIP2 regulates psychostimulant behaviors through its interaction with a membrane protein. Hamilton PJ, Belovich AN, Khelashvili G, Saunders C, Erreger K, Javitch JA, Sitte HH, Weinstein H, Matthies HJG, Galli A (2014) Nat Chem Biol 10: 582-589 The prostaglandin E2 EP2 receptor accelerates disease progression and inflammation in a model of amyotrophic lateral sclerosis. Liang X, Wang Q, Shi J, Lokteva L, Breyer RM, Montine TJ, Andreasson K (2008) Ann Neurol 64: 304-14 Interleukin-2/interleukin-2 antibody therapy induces target organ natural killer cells that inhibit central nervous system inflammation. Hao J, Campagnolo D, Liu R, Piao W, Shi S, Hu B, Xiang R, Zhou Q, Vollmer T, Van Kaer L, La Cava A, Shi FD (2011) Ann Neurol 69: 721-34 A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. Strohmaier C, Carter BD, Urfer R, Barde YA, Dechant G (1996) EMBO J 15: 3332-7 Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s). Pendergast JS, Oda GA, Niswender KD, Yamazaki S (2012) Proc Natl Acad Sci U S A 109: 14218-23 The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants. Mergy MA, Gowrishankar R, Gresch PJ, Gantz SC, Williams J, Davis GL, Wheeler CA, Stanwood GD, Hahn MK, Blakely RD (2014) Proc Natl Acad Sci U S A 111: E4779-88 Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Conn PJ, Jones CK, Lindsley CW (2009) Trends Pharmacol Sci 30: 148-55 Alcohol exposure alters NMDAR function in the bed nucleus of the stria terminalis. Kash TL, Baucum AJ, Conrad KL, Colbran RJ, Winder DG (2009) Neuropsychopharmacology 34: 2420-9 RNA editing as a therapeutic target for CNS disorders. Morabito MV, Emeson RB (2009) Neuropsychopharmacology 34: 246 Alcohol inhibits NR2B-containing NMDA receptors in the ventral bed nucleus of the stria terminalis. Kash TL, Matthews RT, Winder DG (2008) Neuropsychopharmacology 33: 1379-90 Developmental consequences of fetal exposure to drugs: what we know and what we still must learn. Ross EJ, Graham DL, Money KM, Stanwood GD (2015) Neuropsychopharmacology 40: 61-87 Neurotherapeutics. Smith GS, Li X, Conn PJ (2012) Neuropsychopharmacology 37: 1-3 Antipsychotic drug-like effects of the selective M4 muscarinic acetylcholine receptor positive allosteric modulator VU0152100. Byun NE, Grannan M, Bubser M, Barry RL, Thompson A, Rosanelli J, Gowrishankar R, Kelm ND, Damon S, Bridges TM, Melancon BJ, Tarr JC, Brogan JT, Avison MJ, Deutch AY, Wess J, Wood MR, Lindsley CW, Gore JC, Conn PJ, Jones CK (2014) Neuropsychopharmacology 39: 1578-93 Phosphorylation of DARPP-32 at Threonine-34 is required for cocaine action. Zachariou V, Sgambato-Faure V, Sasaki T, Svenningsson P, Berton O, Fienberg AA, Nairn AC, Greengard P, Nestler EJ (2006) Neuropsychopharmacology 31: 555-62 The orexins/hypocretins and schizophrenia. Deutch AY, Bubser M (2007) Schizophr Bull 33: 1277-83 Methamphetamine-induced toxicity: an updated review on issues related to hyperthermia. Matsumoto RR, Seminerio MJ, Turner RC, Robson MJ, Nguyen L, Miller DB, O'Callaghan JP (2014) Pharmacol Ther 144: 28-40 Caffeine: a cause of insulin resistance? Biaggioni I, Davis SN (2002) Diabetes Care 25: 399-400 Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Colbran RJ, Brown AM (2004) Curr Opin Neurobiol 14: 318-27 Differential activation of orexin neurons by antipsychotic drugs associated with weight gain. Fadel J, Bubser M, Deutch AY (2002) J Neurosci 22: 6742-6 Multiple transcriptional mechanisms control Ptf1a levels during neural development including autoregulation by the PTF1-J complex. Meredith DM, Masui T, Swift GH, MacDonald RJ, Johnson JE (2009) J Neurosci 29: 11139-48 Distinct functional roles of the metabotropic glutamate receptors 1 and 5 in the rat globus pallidus. Poisik OV, Mannaioni G, Traynelis S, Smith Y, Conn PJ (2003) J Neurosci 23: 122-30 Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS. Yin S, Noetzel MJ, Johnson KA, Zamorano R, Jalan-Sakrikar N, Gregory KJ, Conn PJ, Niswender CM (2014) J Neurosci 34: 79-94 Induction of hypertension and peripheral inflammation by reduction of extracellular superoxide dismutase in the central nervous system. Lob HE, Marvar PJ, Guzik TJ, Sharma S, McCann LA, Weyand C, Gordon FJ, Harrison DG (2010) Hypertension 55: 277-83, 6p following 283 Modafinil elicits sympathomedullary activation. Taneja I, Diedrich A, Black BK, Byrne DW, Paranjape SY, Robertson D (2005) Hypertension 45: 612-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.